NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 19.4
(-8.92%)
TWD 19.4
(-8.92%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 64.88 Million TWD | 27.01% |
| 2022 | 51.08 Million TWD | -36.32% |
| 2021 | 80.22 Million TWD | 33.86% |
| 2020 | 59.92 Million TWD | -18.91% |
| 2019 | 73.9 Million TWD | 75.85% |
| 2018 | 42.02 Million TWD | 43.82% |
| 2017 | 29.22 Million TWD | 161.13% |
| 2016 | 11.19 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 58.98 Million TWD | 0.0% |
| 2024 Q1 | 58.98 Million TWD | -9.1% |
| 2023 FY | 64.88 Million TWD | 27.01% |
| 2023 Q3 | 64.88 Million TWD | 4.08% |
| 2023 Q4 | 64.88 Million TWD | 0.0% |
| 2023 Q2 | 62.34 Million TWD | 0.0% |
| 2023 Q1 | 62.34 Million TWD | 22.03% |
| 2022 FY | 51.08 Million TWD | -36.32% |
| 2022 Q4 | 51.08 Million TWD | 0.0% |
| 2022 Q2 | 91.98 Million TWD | 0.0% |
| 2021 Q2 | 55.06 Million TWD | 0.0% |
| 2021 FY | 80.22 Million TWD | 33.86% |
| 2021 Q4 | 80.22 Million TWD | 0.0% |
| 2020 Q4 | 59.92 Million TWD | 0.0% |
| 2020 FY | 59.92 Million TWD | -18.91% |
| 2020 Q2 | 72.34 Million TWD | 0.0% |
| 2019 Q4 | 73.9 Million TWD | 0.0% |
| 2019 FY | 73.9 Million TWD | 75.85% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -827.752% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 88.879% |
| Level Biotechnology Inc. | 273.2 Million TWD | 76.249% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 52.92% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 67.141% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 95.113% |
| GlycoNex Incorporation | 276.39 Million TWD | 76.524% |
| VBI | 21.25 Million TWD | -205.336% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 79.316% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 87.392% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -205.696% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 82.384% |
| Visgeneer Inc. | 185.6 Million TWD | 65.04% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 95.096% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 91.148% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 45.864% |
| Neith Corporation | 17.43 Million TWD | -272.208% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 97.111% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -880.462% |
| Enimmune corporation | 173.46 Million TWD | 62.593% |
| TaiRx, Inc. | 60.62 Million TWD | -7.03% |
| CHO Pharma, Inc. | 110.83 Million TWD | 41.455% |
| EirGenix Inc. | 1.14 Billion TWD | 94.333% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 42.055% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 87.338% |
| Lin BioScience, Inc. | 167.73 Million TWD | 61.315% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 30.761% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -2.94% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 47.978% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 59.712% |
| RBC Bioscience Corporation | 513.08 Million TWD | 87.353% |
| BiOptic Inc. | 170.56 Million TWD | 61.957% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -53.914% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -179.024% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -141.998% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 93.342% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -713.936% |
| NaviFUS Corp. | 53.4 Million TWD | -21.509% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 86.524% |
| Sinew Pharma Inc. | 39.71 Million TWD | -63.386% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -11.799% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 82.197% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 71.503% |
| AP Biosciences Inc | 106.65 Million TWD | 39.159% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 98.162% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -111.489% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 66.893% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 95.795% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 92.511% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -599.515% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -16.258% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 72.147% |
| TCI GENE Inc. | 155.54 Million TWD | 58.285% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -154.379% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -40.524% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 80.246% |
| PharmaEngine, Inc. | 91 Million TWD | 28.7% |
| Savior Lifetec Corporation | 457.95 Million TWD | 85.831% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 41.512% |
| OBI Pharma, Inc. | 650.44 Million TWD | 90.024% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 83.397% |
| Acepodia, Inc. | 384.47 Million TWD | 83.123% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 24.156% |